← Back to Search

Other

DZD2269 for Prostate Cancer

Phase 1
Waitlist Available
Research Sponsored by Dizal Pharmaceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through the study completion, an average of around 1 year
Awards & highlights

Study Summary

This study is evaluating whether a new drug can be used to treat prostate cancer.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through the study completion, an average of around 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through the study completion, an average of around 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of AEs and SAEs
Incidence of DLTs
Secondary outcome measures
Area under the plasma concentration-time curve (AUC) of DZD2269
Disease Control Rate (DCR);
Drug concentrations of DZD2269 in plasma and urine
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: DZD2269 as monotherapyExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
DZD2269
2021
Completed Phase 1
~80

Find a Location

Who is running the clinical trial?

Dizal PharmaceuticalsLead Sponsor
20 Previous Clinical Trials
2,033 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Assess the Safety, Tolerability, PK and Anti-tumor Efficacy of DZD2269 in Patients With MCRPC
2021. "Assess the Safety, Tolerability, PK and Anti-tumor Efficacy of DZD2269 in Patients With MCRPC". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04634344.
~4 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top